Cargando…
Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain
Opioids continue to be first-line pharmacotherapy for patients suffering from cancer pain. Unfortunately, subtherapeutic dosage prescribing of pain medications remains common, and many cancer patients continue to suffer and experience diminished quality of life. A large variety of therapeutic option...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145844/ https://www.ncbi.nlm.nih.gov/pubmed/25170278 http://dx.doi.org/10.2147/JPR.S36446 |